SE400280B - 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner - Google Patents

2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner

Info

Publication number
SE400280B
SE400280B SE7314685A SE7314685A SE400280B SE 400280 B SE400280 B SE 400280B SE 7314685 A SE7314685 A SE 7314685A SE 7314685 A SE7314685 A SE 7314685A SE 400280 B SE400280 B SE 400280B
Authority
SE
Sweden
Prior art keywords
substituted
trialkoxikinaz
trialcoxikinazolines
halogen
amino
Prior art date
Application number
SE7314685A
Other languages
English (en)
Inventor
H-J E Hess
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE400280B publication Critical patent/SE400280B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7314685A 1970-05-21 1973-10-29 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner SE400280B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3954170A 1970-05-21 1970-05-21
US24086572A 1972-04-03 1972-04-03

Publications (1)

Publication Number Publication Date
SE400280B true SE400280B (sv) 1978-03-20

Family

ID=26716233

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7105610A SE384211B (sv) 1970-05-21 1971-04-29 Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE7314685A SE400280B (sv) 1970-05-21 1973-10-29 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7105610A SE384211B (sv) 1970-05-21 1971-04-29 Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner

Country Status (10)

Country Link
US (2) US3669968A (sv)
JP (1) JPS5268191A (sv)
AT (1) AT308120B (sv)
BE (1) BE766444A (sv)
CH (1) CH521353A (sv)
DE (2) DE2120495C2 (sv)
FR (1) FR2092154B1 (sv)
GB (1) GB1309835A (sv)
NL (1) NL178594C (sv)
SE (2) SE384211B (sv)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980650A (en) * 1972-05-05 1976-09-14 N.V. Koninklijke Pharmaceutische Fabrieken V/H Brocades-Stheeman En Pharmacia 4-Amino-pyrimidine derivatives
GB1383409A (en) * 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
JPS4966691A (sv) * 1972-10-30 1974-06-27
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4060615A (en) * 1976-02-18 1977-11-29 Mead Johnson & Company 2-Piperazinyl-6,7-dimethoxyquinazolines
DK140695C (da) 1976-05-07 1980-05-12 Synthelabo Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf
SE435380B (sv) 1976-06-15 1984-09-24 Pfizer Forfarande for framstellning av kinazolinforeningar
US4171363A (en) * 1977-02-22 1979-10-16 Bristol-Myers Company 1,2,3-Thiadiazole process
US4101548A (en) * 1977-02-22 1978-07-18 Bristol-Myers Company 1,2,3-Thiadiazole amides
US4098788A (en) * 1977-06-20 1978-07-04 Bristol-Myers Company Process for preparing quinazolines
US4102885A (en) * 1977-06-20 1978-07-25 Bristol-Myers Company Process for preparing 2,4-dihaloquinazolines
US4130647A (en) * 1977-07-08 1978-12-19 Pfizer Inc. Methods for treating congestive heart failure and ischemic heart disease
DK154082C (da) * 1977-11-05 1989-02-27 Pfizer Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US4351940A (en) * 1980-03-03 1982-09-28 Pfizer Inc. Chloro- and alkoxy-substituted-2-chloro-4-aminodquinazolines
US4377581A (en) * 1980-03-03 1983-03-22 Pfizer Inc. Chloro- and alkoxy-substituted-2,4-diaminoquinazolines
US4510307A (en) * 1980-08-20 1985-04-09 Asahi Kasei Kogyo Kabushiki Kaisha 6-Quinazolinesulfonyl derivatives and process for preparation thereof
FI70411C (fi) 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4582832A (en) * 1984-10-09 1986-04-15 Pfizer Inc. Trimazosin as an anti-atherosclerosis agent
GB8910722D0 (en) * 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
DE69406945T2 (de) * 1993-10-18 1998-03-12 Ici Plc Katalytisches verfahren
WO2002024667A1 (en) * 2000-09-20 2002-03-28 Merck Patent Gmbh 4-amino-quinazolines
EP1545519B1 (en) 2002-08-19 2011-03-23 Pfizer Inc. Combination therapy for hyperproliferative diseases
US7759336B2 (en) * 2002-12-10 2010-07-20 Ono Pharmaceutical Co., Ltd. Nitrogen-containing heterocyclic compounds and medicinal use thereof
SG141430A1 (en) * 2003-05-30 2008-04-28 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
EP1768964A1 (en) * 2004-07-06 2007-04-04 Angion Biomedica Corporation Quinazoline modulators of hepatocyte growth factor / c-met activity for the treatment of cancer
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2007081978A2 (en) * 2006-01-11 2007-07-19 Angion Biomedica Corporation Modulators of hepatocyte growth factor / c-met activity
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
CL2007000667A1 (es) * 2006-03-14 2008-03-14 Ranbaxi Lab Ltd Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
AU2007274724B2 (en) * 2006-07-14 2012-07-26 Ranbaxy Laboratories Limited Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives

Also Published As

Publication number Publication date
US3669968A (en) 1972-06-13
JPS5268191A (en) 1977-06-06
DE2120495A1 (de) 1971-12-02
SE384211B (sv) 1976-04-26
FR2092154B1 (sv) 1975-01-17
BE766444A (fr) 1971-10-29
DE2120495C2 (de) 1982-06-03
NL178594B (nl) 1985-11-18
US3769286A (en) 1973-10-30
GB1309835A (en) 1973-03-14
AT308120B (de) 1973-06-25
FR2092154A1 (sv) 1972-01-21
NL178594C (nl) 1986-04-16
NL7106029A (sv) 1971-11-23
CH521353A (fr) 1972-04-15
DE2167157C2 (de) 1982-06-09
JPS5439386B2 (sv) 1979-11-27

Similar Documents

Publication Publication Date Title
SE400280B (sv) 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE390414B (sv) 14,15-dioxo-e-homo-eburnaner som mellanprodukt for framstellning av vinkamin
SE384368B (sv) Forfarande for framstellning av 6-substituerade - 4 - amino- 1,2 - dihydro - 1 - hydroxi - 2 - iminopyrimidiner
SE7409801L (sv) Forfarande for framstellning av kinolinforeningar.
SE399427B (sv) Forfarande for framstellning av 2,4 diamino-bensylpyrimidiner
SE399879B (sv) Kemiska mellanprodukter till anvendning for framstellning av terapeutiskt verdefulla 1,2,3,4-tetrahydro-4-fenyl-isokinolinderivat
DK138382B (da) 2-phosphono-butan-1,2,4-tricarbo-xylsyrederivater til anvendelse som kompleksdannere samt fremstilling deraf
SE396592B (sv) Foreningen difluorometyl-2,2,3,3-tetrafluoropropyleter till anvendning som mellanprodukt vid framstellning av difluormetyl-1,2,2,3,3-pentafluoropropyleter
FI49827C (sv) Förfarande för framställning av substituerade 3-hydroximetyl-isokinoli ner med terapeutisk verkan.
FI52090C (sv) Förfarande för framställning av antimikrobt 2-amino-4-hydroxi-7,7-dime tyl-7,8-dihydropteridin
FI49504C (sv) Förfarande för framställning av farmakologiskt versamma bensocyklohept aisokinolinderivat.
NO144170C (no) Fremgangsmaate til fremstilling av desacetoksy-cefalosporansyrederivater.
SE388611B (sv) Analogiforfarande for framstellning av 1,4-bensodiazeponderivat
SE413506B (sv) 2,4-diaminopyrimidinforeningar till anvendning som utgangsmaterial for framstellning av 2,4-diamino-5-bensylpyrimidiner
FI53825B (fi) Framstaellning av etylenpropylenkopolymer med trifenylfosfit som katalysatorhjaelpmedel
SE389333B (sv) Forfarande for framstellning av ackalipolyfosfatkomplex av x-6-desoxi-5-hydroxitetsacyklin.
SE380263B (sv) Forfarande for framstellning av 10-oxo-7,10-dihydro-1h-dioxino-(5,4-f)-9-kinolyl-karbonsyror
NO144069C (no) Difluorbutyrofenonderivater som er anvendelige for fremstilling av terapeutisk aktive butyrofenonderivater
SE385295B (sv) 2-fenyliminopyrrolidiner till anvendning som akaricider
SE410463B (sv) Metylcyklohexyl-o-anisylfosfin till anvendning som mellanprodukt for framstellning av optiskt aktiva hydreringskatalysatorer
SE382062B (sv) Forfarande for framstellning av acylpropandiol-(1,3)-fosforsyra-kolinestrar
SE401366B (sv) Forfarande for framstellning av 2,6-metano-3-bensazociner
TR17509A (tr) Tiazolidinlerin 4,5-bis-trifluorometilimino tuerevlerinin imaline mahsus usul
SE414306B (sv) Forfarande for framstellning av 1,4-bensodiazepiner
SE417196B (sv) Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer